SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001607062-15-000302
Filing Date
2015-07-07
Accepted
2015-07-07 17:11:19
Documents
1
Period of Report
2015-07-07
Effectiveness Date
2015-07-07

Document Format Files

Seq Description Document Type Size
1 DEF 14A gnbt60215sch14a.htm DEF 14A 571499
  Complete submission text file 0001607062-15-000302.txt   572566
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANADA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
Type: DEF 14A | Act: 34 | File No.: 000-25169 | Film No.: 15977141
SIC: 2834 Pharmaceutical Preparations